Akademikliniken, Storängsvägen 10, 115 42, Stockholm, Sweden.
Aesthetic Plast Surg. 2020 Aug;44(4):1295-1299. doi: 10.1007/s00266-020-01772-5.
After the introduction of facial aesthetic injectables with botulinum toxin (BoNt) in the first half of the 1990s and nonanimal-based hyaluronic acid (HA) fillers in 1996, the interest for minimally invasive procedures has exploded. With this background, it is not surprising that the interest for body contouring with HA has also attracted a lot of interest. The effectiveness and safety for breast augmentation, buttock augmentation and treatment for pectus excavatum has been extensively investigated and published. Generally, patient satisfaction has been high and complications low. Due to several factors such as limited duration and unfavorable cost, HA fillers have been withdrawn from the market. With the development of new HA products, it is possible that its use for body contouring will be reintroduced and popular in the future.
自 20 世纪 90 年代上半叶推出含有肉毒毒素(BoNt)的面部美学注射剂和 1996 年推出非动物源透明质酸(HA)填充物以来,微创治疗的兴趣呈爆炸式增长。在此背景下,人们对使用 HA 进行身体塑形的兴趣也很大也就不足为奇了。HA 用于隆胸、丰臀和漏斗胸治疗的有效性和安全性已得到广泛研究和发表。一般来说,患者满意度高,并发症少。由于持续时间有限和成本不利等因素,HA 填充物已退出市场。随着新型 HA 产品的发展,其在身体塑形方面的应用可能会重新引入并在未来流行。